5 completed. 5 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 5 | Completed 5 |
Follow TER 286: new trials by email Literature Review of TER 286 trials Research Report on TER 286
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer TLK286, carboplatin, paclitaxel - Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | Completed | Telik | 100 | 2004-08-01 | 2012-05-31 |
| TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) TLK286, cisplatin - Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Completed | Telik | 50 | 2004-02-01 | 2011-07-25 |
| TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer TLK286 - Ovarian Neoplasms | Phase 1 / Phase 2 | Completed | Telik | 28 | 2003-02-01 | 2011-07-25 |
| TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer TLK286 - Ovarian Neoplasms | Phase 1 / Phase 2 | Completed | Telik | 28 | 2003-01-01 | 2011-07-25 |
| Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer TLK286 in combination with docetaxel - Carcinoma, Non-small-cell Lung | Phase 1 / Phase 2 | Completed | Telik | 28 | 2002-10-01 | 2011-07-25 |
Carcinoma, Non-Small-Cell Lung (3) · Ovarian Neoplasms (2)
Telik (5)
United States (5)